Corporate action Novo Nordisk A/S

At Novo Nordisk A/S there was a corporate action (split 2:1) as of 15/09/2023. Furthermore, as of 15/09/2023 there was a change of ISIN for DK0060534915 (B share) to DK0062498333.

Affected product: Citi Multi Memory Express Anleihe Pharma 23-28 (XS2650758431)

This product is still in subscription. Strike and barrier will be fixed on 28/09/2023, thus the corporate action has no impact on this product.